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Main Text
Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN or NBIA4) is caused by biallelic mutations in the C19orf12 gene. MPAN accounts for the largest proportion of NBIA after PKAN (PANK2 mutations) and PLAN (PLA2G6 mutations). It is characterized by juvenile-onset spastic paraparesis, levodopa-unresponsive parkinsonism, dystonia and neuropsychiatric symptoms.
Additional features are optic atrophy, dysphagia, dysarthria, and motor axonal neuropathy. Brain MRI displays T2-weighted symmetrical hypointensities in globus pallidus (GP) and substantia nigra (SN) [1] . Missense, frameshift and nonsense mutations were found in exons 2 and 3 of C19orf12 (NM_001031726 transcript). One splice-site mutation (c.194-2A>G) was identified in intron 2 ( Figure 1a ). Specific variants were found to be frequent in MPAN cases of selected populations (c.204_214del -p.G69Rfs*10 in Eastern Europeans and p.T11M in Turkish) [2, 3] . Here we report a case of NBIA with a novel C19orf12 mutation with molecular evidence of de novo occurrence
The relevant ethical authorities approved the study and written informed consent was obtained from all involved subjects. The proband is the only child of non-consanguineous Italian parents. Familial history was negative for neurological disorders (Figure 1b) . She was born at term by spontaneous delivery after an uneventful pregnancy. Motor development was at first normal, while a delay in language development was reported at the age of 3. Height-weight growth has been always at the lower normal limits (3-10 centiles). At the age of 5 she developed a progressive imbalanced gait associated with lower limbs rigidity and later onset of right hand dystonia forced her to use the left hand to write. She developed mild hirsutism at 9 years (pubis and limbs) and precocious puberty. In order to explore a possible mosaicism, the mutation was studied in DNA from several tissues (hair, saliva and urine). The presence of the p.M89Gfs*12 in all tissues suggests a germ-line mosaicism in a parent.
MPAN is considered an autosomal recessive disorder; however, five monoallelic C19orf12 mutations have been already described [1, 3, 4] . A second occult mutation was suspected to be present in these cases. Deletion screening and promoter regions sequencing in some of these cases did not identified a second mutation [1, 3, 4] . Interestingly, all these mutations localize on exon 3 (G69R, p.Q86*, p.A94Cfs*8, p.A120Gfs*32 and p.L99fs*102), including deleterious frameshift/stop mutations on the C19orf12 C-terminal domain, as in the case described in this study. Moreover, in a family with a heterozygous p.A120Gfs*32 mutation family history suggested a possible autosomal-dominant inheritance; indeed, the father of the patient, who died at age 47 following a long course of progressive dementia with parkinsonism, showed a typical MPAN neuropathology at postmortem examination [3] . 
